Publications by authors named "Shraboni Ghosal"
Introduction: People with type 2 diabetes can experience diabetes distress which can negatively affect health outcomes. Non-pharmacological interventions such as mindfulness can help address diabetes distress. However, face-to-face programmes can be constrained by cost, poor accessibility and lack of availability.
View Article and Find Full Text PDFArticle Synopsis
- - Orlistat is suggested as a supplementary treatment for weight loss alongside diet and exercise in individuals with type 2 diabetes mellitus (T2DM), particularly focusing on patient demographics and prescribing practices.
- - A study using health records of over 100,000 patients found that orlistat was prescribed to only a small percentage of T2DM and prediabetes patients, with factors like younger age, gender, socioeconomic status, smoking, and co-prescription of metformin influencing prescriptions.
- - Patients who continued orlistat for 12 weeks were more likely to achieve significant weight loss, whereas those who stopped early were less likely to experience similar results, highlighting the importance of adhering to the medication for effective outcomes.